Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jan;35(1):479-486.
doi: 10.1007/s00330-024-10961-8. Epub 2024 Jul 18.

Diagnostic ability of [18F]FDG PET/CT for distinguishing benign from malignant spleen lesions

Dong Yun Lee  1 , Yong-Il Kim  2 , Jin-Sook Ryu  1
Affiliations

Diagnostic ability of [18F]FDG PET/CT for distinguishing benign from malignant spleen lesions

Dong Yun Lee et al. Eur Radiol. 2025 Jan.

Abstract

Objectives: [18F]Fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) is a non-invasive imaging modality used in the differential diagnosis of splenic lesions, although ideal parameters and thresholds remain unclear. The present study evaluated the ability of [18F]FDG PET/CT, including its visual and quantitative parameters, to differentiate between benign and malignant splenic lesions.

Methods: Patients who underwent [18F]FDG PET/CT following the detection of splenic lesions on contrast-enhanced CT were retrospectively analysed. Visual parameters assessed on [18F]FDG PET/CT included whole spleen uptake intensity, lesion multiplicity, and lesion uptake, and quantitative parameters included maximum standardised uptake value (SUVmax), lesion-to-background ratio (LBR), metabolic tumour volume (MTV), total lesion glycolysis (TLG), and lesion size. Parameters differentiating between benign and malignant lesions were evaluated by Pearson's chi-square test, Mann-Whitney U-test, and receiver operating characteristics (ROC) curve analysis.

Results: Splenic lesion uptake (p = 0.001) was the only visual parameter significantly distinguishing between benign and malignant lesions. ROC curve analysis demonstrated that SUVmax had the largest area under the ROC, 0.91 (p < 0.001), with an optimal cut-off > 5.3 having a sensitivity of 90.3% and a specificity of 80.6%. Subgroup analysis of malignant lesions showed that SUVmax (p = 0.013), LBR (p = 0.012), and TLG (p = 0.034) were significantly higher in splenic lymphomas than in splenic metastases.

Conclusion: Of the [18F]FDG PET/CT parameters investigated, SUVmax had the highest accuracy in diagnosing malignant splenic lesions and was significantly higher in splenic lymphomas than in splenic metastases. Visual determination of [18F]FDG uptake by splenic lesions may be an easily evaluated parameter.

Clinical relevance statement: SUVmax and visual grade of [18F]FDG PET/CT help to differentiate spleen lesions. [18F]FDG PET/CT is useful for discriminating between benign and malignant spleen lesions.

Key points: Many splenic lesions are difficult to diagnose on anatomical imaging, with histopathologic analyses are required. SUVmax of PET/CT provided the diagnostic ability to differentiate between benign and malignant splenic lesions. More than normal spleen uptake can be a convenient parameter to diagnose malignant spleen lesions.

Keywords: Fluorodeoxyglucose F18; Positron emission tomography-computed tomography; Sensitivity and specificity; Spleen neoplasms.

PubMed Disclaimer

Conflict of interest statement

Compliance with ethical standards. Guarantor: The scientific guarantor of this publication is Y.-i. Kim. Conflict of interest: The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article. Statistics and biometry: Two of the authors (Y.-i. Kim and D.Y. Lee) have significant statistical expertise. Informed consent: Written informed consent was waived by the Institutional Review Board. Ethical approval: Institutional Review Board approval was obtained. Study subjects or cohorts overlap: No study subjects or cohorts have been previously reported. Methodology: Retrospective Diagnostic or prognostic study Performed at one institution

Similar articles

See all similar articles

References

    1. Skandalakis PN, Colborn GL, Skandalakis LJ, Richardson DD, Mitchell WE Jr, Skandalakis JE (1993) The surgical anatomy of the spleen. Surg Clin North Am 73:747–768 - DOI - PubMed
    1. Kim N, Auerbach A, Manning MA (2022) Algorithmic approach to the splenic lesion based on radiologic-pathologic correlation. Radiographics 42:683–701 - DOI - PubMed
    1. Thipphavong S, Duigenan S, Schindera ST, Gee MS, Philips S (2014) Nonneoplastic, benign, and malignant splenic diseases: cross-sectional imaging findings and rare disease entities. AJR Am J Roentgenol 203:315–322 - DOI - PubMed
    1. Venkataramu NK, Gupta S, Sood BP et al (1999) Ultrasound guided fine needle aspiration biopsy of splenic lesions. Br J Radiol 72:953–956 - DOI - PubMed
    1. Keogan MT, Freed KS, Paulson EK, Nelson RC, Dodd LG (1999) Imaging-guided percutaneous biopsy of focal splenic lesions: update on safety and effectiveness. AJR Am J Roentgenol 172:933–937 - DOI - PubMed

Substances

LinkOut - more resources